Trial watch: DNA-based vaccines for oncological indications

Trial watch: DNA-based vaccines for oncological indications

DNA-based vaccination is a promising approach to cancer immunotherapy. DNA-based vaccines specific for tumor-associated antigens (TAAs) are indeed relatively simple to produce, cost-efficient and well tolerated. However, the clinical efficacy of DNA-based vaccines for cancer therapy is considerably...

Full description

Bibliographic Details
Main Authors: Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene, Lorenzo Galluzzi
Format: Article
Language:English
Published: Taylor & Francis Group 2017-12-01
Series:OncoImmunology
Subjects:
adenovirus
cancer testis antigens
ctla4
electroporation
padre
pd-1
tricom
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1398878

Internet

http://dx.doi.org/10.1080/2162402X.2017.1398878

Similar Items